520880 港股通创新药ETF华宝
已收盘 10-19 15:00:00
资讯
新帖
简况
港股通创新药止跌向上,520880标的指数摸高4.7%!药明康德尾盘突发跳水,发生了什么?
新浪基金 · 10-16 19:57
港股通创新药止跌向上,520880标的指数摸高4.7%!药明康德尾盘突发跳水,发生了什么?
跌到位了?创新药逆市活跃,药ETF(562050)成功收红,港股通创新药ETF华宝跑赢大市!ESMO大会下周启幕
新浪基金 · 10-15
跌到位了?创新药逆市活跃,药ETF(562050)成功收红,港股通创新药ETF华宝跑赢大市!ESMO大会下周启幕
【ETF动向】10月14日港股通创新药ETF华宝基金跌3.01%,份额增加5200万份
证券之星 · 10-15
【ETF动向】10月14日港股通创新药ETF华宝基金跌3.01%,份额增加5200万份
ETF午评|上证指数涨0.01%,消费板块走强,影视ETF、港股通互联网ETF涨3%,港股通创新药ETF再跌2%
格隆汇 · 10-14
ETF午评|上证指数涨0.01%,消费板块走强,影视ETF、港股通互联网ETF涨3%,港股通创新药ETF再跌2%
多重利好持续发酵,创新药攻势再起!场内热门标的520880、159137逆市上扬
新浪基金 · 09-23
多重利好持续发酵,创新药攻势再起!场内热门标的520880、159137逆市上扬
ETF午评|上证指数涨0.55%,创新药板块大爆发,恒生创新药ETF、港股通创新药医疗ETF涨超5%
格隆汇 · 09-21
ETF午评|上证指数涨0.55%,创新药板块大爆发,恒生创新药ETF、港股通创新药医疗ETF涨超5%
调仓提示!华宝基金港股通创新药ETF(520880)成份股“5进3出”,复宏汉霖等多只新入通标的获纳入
新浪基金 · 09-15
调仓提示!华宝基金港股通创新药ETF(520880)成份股“5进3出”,复宏汉霖等多只新入通标的获纳入
创新药跌跌不休,什么原因?华宝基金港股通创新药ETF(520880)失守所有均线
新浪基金 · 09-13
创新药跌跌不休,什么原因?华宝基金港股通创新药ETF(520880)失守所有均线
重磅大会在前,创新药未有起色,什么情况?华宝基金港股通创新药ETF(520880)失守所有均线
新浪基金 · 09-11
重磅大会在前,创新药未有起色,什么情况?华宝基金港股通创新药ETF(520880)失守所有均线
创新药企密集进入临床数据验证期,石药集团涨超4%!华宝基金港股通创新药ETF(520880)再收半年线!
新浪基金 · 09-03
创新药企密集进入临床数据验证期,石药集团涨超4%!华宝基金港股通创新药ETF(520880)再收半年线!
【ETF动向】8月27日港股通创新药ETF华宝基金涨1.27%,份额减少1.5亿份
证券之星 · 08-28
【ETF动向】8月27日港股通创新药ETF华宝基金涨1.27%,份额减少1.5亿份
创新药反复活跃,后市怎么走?华宝基金港股通创新药ETF(520880)基金经理火线拆解行情逻辑!
新浪基金 · 08-27
创新药反复活跃,后市怎么走?华宝基金港股通创新药ETF(520880)基金经理火线拆解行情逻辑!
【ETF动向】8月25日港股通创新药ETF华宝基金涨1.1%,份额减少7000万份
证券之星 · 08-26
【ETF动向】8月25日港股通创新药ETF华宝基金涨1.1%,份额减少7000万份
创新药火速修复,520880成反弹急先锋!场内唯一药ETF8天7涨!映恩生物、艾力斯、荣昌生物等多股释放利好
新浪基金 · 07-20
创新药火速修复,520880成反弹急先锋!场内唯一药ETF8天7涨!映恩生物、艾力斯、荣昌生物等多股释放利好
港股通创新药突遭重挫,520880放量溢价!A股制药板块韧性凸显,场内唯一药ETF周线逆市收红
新浪基金 · 07-19
港股通创新药突遭重挫,520880放量溢价!A股制药板块韧性凸显,场内唯一药ETF周线逆市收红
创新药遭“错杀”?AH十余股狂泻逾10%!港股通创新药ETF(520880)、场内唯一药ETF同创历史最大单日跌幅
新浪基金 · 07-17
创新药遭“错杀”?AH十余股狂泻逾10%!港股通创新药ETF(520880)、场内唯一药ETF同创历史最大单日跌幅
【ETF动向】7月15日港股通创新药ETF华宝基金涨3.81%,份额减少1.1亿份
证券之星 · 07-16
【ETF动向】7月15日港股通创新药ETF华宝基金涨3.81%,份额减少1.1亿份
创新药再度活跃!场内唯一药ETF(562050)逆市涨超1%四连升!港股通创新药ETF华宝(520880)盘中翻红!
新浪基金 · 07-14
创新药再度活跃!场内唯一药ETF(562050)逆市涨超1%四连升!港股通创新药ETF华宝(520880)盘中翻红!
【ETF动向】7月10日港股通创新药ETF华宝基金涨3.46%,份额减少1.1亿份
证券之星 · 07-11
【ETF动向】7月10日港股通创新药ETF华宝基金涨3.46%,份额减少1.1亿份
19亿美元!国产创新药叒爆BD大单!港股通创新药应声反弹,520880摸高2.54%
新浪基金 · 07-09
19亿美元!国产创新药叒爆BD大单!港股通创新药应声反弹,520880摸高2.54%
公司概况
公司名称:
--
所属市场:
上市日期:
--
主营业务:
发行价格:
--
{"stockData":{"symbol":"520880","market":"SH","secType":"STK","nameCN":"港股通创新药ETF华宝","latestPrice":0.426,"timestamp":1792393200000,"preClose":0.423,"halted":0,"volume":288121100,"delay":0,"changeRate":0.0071,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":0.003,"latestTime":"10-19 15:00:00","open":0.421,"high":0.427,"low":0.421,"amount":122000000,"amplitude":0.0142,"askPrice":0.426,"askSize":76100,"bidPrice":0.425,"bidSize":147344,"shortable":0,"etf":1,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792459800000},"marketStatusCode":5,"adr":0,"adjPreClose":0.423,"symbolType":"fund","openAndCloseTimeList":[[1792373400000,1792380600000],[1792386000000,1792393200000]],"highLimit":0.465,"lowLimit":0.381,"ibTradeSell":false,"ibTradeBuySell":false,"isCdr":false,"pbRate":0,"committee":0.039944,"marketValue":0,"turnoverRate":0,"status":0,"floatMarketCap":0},"requestUrl":"/m/hq/s/520880/wiki","defaultTab":"wiki","newsList":[{"id":"2675591212","title":"港股通创新药止跌向上,520880标的指数摸高4.7%!药明康德尾盘突发跳水,发生了什么?","url":"https://stock-news.laohu8.com/highlight/detail?id=2675591212","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675591212?lang=zh_cn&edition=full","pubTime":"2026-10-16 19:57","pubTimestamp":1792151820,"startTime":"0","endTime":"0","summary":"10月20-22日上海黄浦江畔,2026可持续全球领导者大会再度来袭。早盘创新药全链反攻,港股通创新药ETF华宝、港股通医疗ETF华宝标的指数分别上探4.7%、3.9%,午后受药明系突发跳水影响涨幅收窄,但最终仍各自收涨1.94%、0.19%。捕捉港股医药高弹性机遇,关注两个T+0交易工具:港股通创新药ETF华宝:标的指数100%布局创新药研发类公司,7成仓位押注创新药研发龙头。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-10-16/doc-inivmpqz6915860.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["603259","BK1576","LU1770034418.SGD","LU1934453819.USD","FLHK","02359","BK1583","BK1141","IE00B543WZ88.USD","LU0348766576.USD","LU0700851271.USD","159992","LU1979443071.USD","LU0469268626.HKD","IE00B5MMRT66.SGD","LU0072913022.USD","LU0320764599.SGD","LNGR","IE00BPRC5H50.USD","LU2045819591.USD","MEDX","LU0106959298.USD","LU1997245177.USD","LU1969619763.USD","LU1046422090.SGD","LU0572944931.SGD","LU2242644610.SGD","LU1808992512.USD","LU2328871848.SGD","LU1303224171.USD","LU2495084118.USD","LU1251922891.USD","LU2488822045.USD","LU0456842615.SGD","520880","LU2125910500.SGD","LU0611395673.USD","BK0216","BK1161","LU0327786744.USD","06978","LU1997245094.SGD","BK1574","LU0501845795.SGD","LU0052750758.USD","LU1997244956.HKD","LU0708995583.HKD","LU0348767384.USD","LU1719994722.HKD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675758139","title":"跌到位了?创新药逆市活跃,药ETF(562050)成功收红,港股通创新药ETF华宝跑赢大市!ESMO大会下周启幕","url":"https://stock-news.laohu8.com/highlight/detail?id=2675758139","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675758139?lang=zh_cn&edition=full","pubTime":"2026-10-15 19:33","pubTimestamp":1792063980,"startTime":"0","endTime":"0","summary":"10月20-22日上海黄浦江畔,2026可持续全球领导者大会再度来袭。10月15日,大市深度调整,A+H创新药资产逆市活跃,带动药ETF华宝成功收红,港股通创新药ETF华宝标的指数微跌0.4%跑赢大市。截至收盘,港股通创新药ETF华宝标的指数走出7连跌,盘中点位创近3个月新低。图:港股通创新药ETF华宝近6月日K走势今日板块未能全面上涨,主要受美联储加息预期升温压制。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-10-15/doc-iniviekf8076114.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["06978","BK1161","BK4550","IBBQ","BK4588","BK4585","MEDX","LNGR","159992","FDN","520880","562050","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675554378","title":"【ETF动向】10月14日港股通创新药ETF华宝基金跌3.01%,份额增加5200万份","url":"https://stock-news.laohu8.com/highlight/detail?id=2675554378","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675554378?lang=zh_cn&edition=full","pubTime":"2026-10-15 06:33","pubTimestamp":1792017191,"startTime":"0","endTime":"0","summary":"证券之星消息,10月14日,港股通创新药ETF华宝基金(520880)跌3.01%,成交额2.73亿元。当日份额增加了5200万份,最新份额为45.42亿份,近20个交易日份额增加1.78亿份。当日资金净流出4640.74万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为19.07亿元。港股通创新药ETF华宝基金跟踪标的为恒生港股通创新药精选指数,成立(2025-06-27)以来超额回报为-3.86%,近一个月超额回报为-0.23%,管理人为华宝基金公司,基金经理为丰晨成。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101500004715.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["520880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675392762","title":"ETF午评|上证指数涨0.01%,消费板块走强,影视ETF、港股通互联网ETF涨3%,港股通创新药ETF再跌2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675392762","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675392762?lang=zh_cn&edition=full","pubTime":"2026-10-14 11:38","pubTimestamp":1791949119,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0201","BK0278","000001","BK0012","513220","BK0028","IE00B0JY6N72.USD","LU1807302812.USD","BK0187","LU1580142542.USD","159619","520880","LU0880133367.SGD","LU0067412154.USD","LU1655091616.SGD","BK0183","513040","LU0072913022.USD","LU1993786604.SGD","159855","BK0188","LU1781817850.SGD","LU0501845795.SGD","LU1226287529.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669210892","title":"多重利好持续发酵,创新药攻势再起!场内热门标的520880、159137逆市上扬","url":"https://stock-news.laohu8.com/highlight/detail?id=2669210892","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669210892?lang=zh_cn&edition=full","pubTime":"2026-09-23 14:31","pubTimestamp":1790145060,"startTime":"0","endTime":"0","summary":"100%创新药研发标的——港股通创新药ETF华宝逆市飘红。AI制药含量、CXO含量双高的港股通医疗ETF华宝逆市走强。政策端,创新药产业再获国家级战略背书。港股通创新药ETF华宝覆盖的50家创新药研发公司中,34家上半年实现盈利,归母净利同比正增长的有36家,占比超7成。全链布局创新药,可关注两个T+0交易工具:港股通创新药ETF华宝:标的指数100%布局创新药研发类公司,7成仓位押注创新药研发龙头。权重数据截至2026.8.31。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-23/doc-inisuxhc8551792.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159992","520880","IBBQ","BK1161","BK1574","LNGR","159137","MEDX","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669348701","title":"ETF午评|上证指数涨0.55%,创新药板块大爆发,恒生创新药ETF、港股通创新药医疗ETF涨超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669348701","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669348701?lang=zh_cn&edition=full","pubTime":"2026-09-21 11:36","pubTimestamp":1789961790,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["520500","520880","159316","513120"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667641935","title":"调仓提示!华宝基金港股通创新药ETF(520880)成份股“5进3出”,复宏汉霖等多只新入通标的获纳入","url":"https://stock-news.laohu8.com/highlight/detail?id=2667641935","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667641935?lang=zh_cn&edition=full","pubTime":"2026-09-15 19:10","pubTimestamp":1789470600,"startTime":"0","endTime":"0","summary":"9月14日,100%布局创新药研发龙头的恒生港股通创新药精选指数季度调整正式生效,被动跟踪该指数的港股通创新药ETF华宝同步调仓换血。成份股“5进3出”,总数回升至50只。港股通创新药ETF华宝标的指数相较同类指数率先导入“新鲜血液”:此次调入的5只成份股中,复宏汉霖、和铂医药-B、基石药业-B、瑞博生物-B等4只均为9月7日新纳入港股通的标的。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-15/doc-inirxhzq8479614.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["HK0000165453.HKD","HK0000306685.HKD","HK0000306701.USD","159316","HK0000320223.HKD","FLHK","02696","HK0000320264.USD","520880","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667684274","title":"创新药跌跌不休,什么原因?华宝基金港股通创新药ETF(520880)失守所有均线","url":"https://stock-news.laohu8.com/highlight/detail?id=2667684274","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667684274?lang=zh_cn&edition=full","pubTime":"2026-09-13 19:25","pubTimestamp":1789298700,"startTime":"0","endTime":"0","summary":"100%创新药研发标的——港股通创新药ETF华宝失守所有均线,重仓A股创新药的药ETF华宝标的指数日K、周K双双五连阴。图:港股通创新药ETF华宝近6月日K走势如何看待创新药本轮调整?低位埋伏创新药,关注两大投资工具:港股通创新药ETF华宝:紧密跟踪恒生港股通创新药精选指数,100%布局创新药研发类公司,前十大权重股占比超七成,龙头属性突出,底层资产是港股,高弹性、T+0。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-13/doc-inirsuvy5397470.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159316","06978","IBBQ","520880","BK1574","LNGR","MEDX","BK1161","FLHK","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666529140","title":"重磅大会在前,创新药未有起色,什么情况?华宝基金港股通创新药ETF(520880)失守所有均线","url":"https://stock-news.laohu8.com/highlight/detail?id=2666529140","media":"新浪基金","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666529140?lang=zh_cn&edition=full","pubTime":"2026-09-11 19:17","pubTimestamp":1789125420,"startTime":"0","endTime":"0","summary":"100%创新药研发标的——港股通创新药ETF华宝失守所有均线,重仓A股创新药的药ETF华宝标的指数日K、周K双双五连阴。图:港股通创新药ETF华宝近6月日K走势如何看待创新药本轮调整?低位埋伏创新药,关注两大投资工具:港股通创新药ETF华宝:紧密跟踪恒生港股通创新药精选指数,100%布局创新药研发类公司,前十大权重股占比超七成,龙头属性突出,底层资产是港股,高弹性、T+0。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-11/doc-inirnhry5675751.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["520880","FLHK","IBBQ","159316","06978","BK1574","LNGR","MEDX","159992","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664231028","title":"创新药企密集进入临床数据验证期,石药集团涨超4%!华宝基金港股通创新药ETF(520880)再收半年线!","url":"https://stock-news.laohu8.com/highlight/detail?id=2664231028","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664231028?lang=zh_cn&edition=full","pubTime":"2026-09-03 10:52","pubTimestamp":1788403920,"startTime":"0","endTime":"0","summary":"9月3日,港股创新药链继续活跃,创新药龙头公司领涨,石药集团、中国生物制药双双涨超4%。纯正创新药指数——恒生港股通创新药精选指数一度冲高逾2%,跟踪该指数的港股通创新药ETF华宝盘中再收半年线。中金公司提示,创新药较多公司进入临床数据验证阶段,值得自下而上关注。据统计,港股通创新药ETF华宝覆盖的48家创新药研发公司中,31家上半年实现盈利,归母净利同比正增长的有33家,占比近7成。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-03/doc-iniqpkry1034045.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IE0008368742.USD","LU1960683339.HKD","BK1191","LU1807302812.USD","IBBQ","LNGR","LU0880133367.SGD","LU1993786604.SGD","LU1008478684.HKD","SG9999004220.SGD","LU1152091168.USD","LU0140636845.USD","159316","LU1328277881.USD","IE00BZ08YR35.GBP","LU0315179316.USD","MEDX","LU0072913022.USD","LU1226287529.USD","159992","IE00B5MMRT66.SGD","LU1813983027.USD","01093","BK1521","HK0000165453.HKD","LU0326950275.SGD","LU1226287792.SGD","IE00B031HY20.USD","LU0501845795.SGD","LU1951186391.HKD","LU1226287875.USD","LU2039709279.SGD","LU1226288253.USD","IE00BZ08YS42.EUR","FLHK","LU1152091754.HKD","LU1226288170.HKD","520880","BK1574","LU0067412154.USD","BK1161","KURE","LU0314109678.HKD","IE00B543WZ88.USD","IE00BZ08YT58.USD","06978","BK1515","IE0008369823.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662039137","title":"【ETF动向】8月27日港股通创新药ETF华宝基金涨1.27%,份额减少1.5亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2662039137","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662039137?lang=zh_cn&edition=full","pubTime":"2026-08-28 06:32","pubTimestamp":1787869958,"startTime":"0","endTime":"0","summary":"证券之星消息,8月27日,港股通创新药ETF华宝基金(520880)涨1.27%,成交额3.93亿元。当日份额减少了1.5亿份,最新份额为44.36亿份,近20个交易日份额减少6.62亿份。当日资金净流出3785.43万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为21.5亿元。港股通创新药ETF华宝基金跟踪标的为恒生港股通创新药精选指数,成立(2025-06-27)以来超额回报为-4.1%,近一个月超额回报为-0.06%,管理人为华宝基金公司,基金经理为丰晨成。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800011987.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["520880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662992722","title":"创新药反复活跃,后市怎么走?华宝基金港股通创新药ETF(520880)基金经理火线拆解行情逻辑!","url":"https://stock-news.laohu8.com/highlight/detail?id=2662992722","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662992722?lang=zh_cn&edition=full","pubTime":"2026-08-27 11:20","pubTimestamp":1787800800,"startTime":"0","endTime":"0","summary":"100%创新药研发标的——港股通创新药ETF华宝关注度持续升温。图:港股通创新药ETF华宝近6个月日K走势如何看待近期创新药行情?港股通创新药ETF华宝基金经理丰晨成最新解读来了,三个维度拆解行情逻辑。全链布局创新药,关注两大T+0交易利器:港股通创新药ETF华宝:被动跟踪恒生港股通创新药精选指数,100%布局创新药研发类公司,7成仓位押注研发龙头。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-08-27/doc-iniptnux9036538.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","BK1574","FLHK","LNGR","520880","06978","159992","IBBQ","159316","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662502357","title":"【ETF动向】8月25日港股通创新药ETF华宝基金涨1.1%,份额减少7000万份","url":"https://stock-news.laohu8.com/highlight/detail?id=2662502357","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662502357?lang=zh_cn&edition=full","pubTime":"2026-08-26 06:32","pubTimestamp":1787697165,"startTime":"0","endTime":"0","summary":"证券之星消息,8月25日,港股通创新药ETF华宝基金(520880)涨1.1%,成交额4亿元。当日份额减少了7000万份,最新份额为46.96亿份,近20个交易日份额减少4.18亿份。当日资金净流出223.9万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为21.96亿元。港股通创新药ETF华宝基金跟踪标的为恒生港股通创新药精选指数,成立(2025-06-27)以来超额回报为-3.92%,近一个月超额回报为-0.07%,管理人为华宝基金公司,基金经理为丰晨成。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600010742.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["520880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652290964","title":"创新药火速修复,520880成反弹急先锋!场内唯一药ETF8天7涨!映恩生物、艾力斯、荣昌生物等多股释放利好","url":"https://stock-news.laohu8.com/highlight/detail?id=2652290964","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652290964?lang=zh_cn&edition=full","pubTime":"2026-07-20 19:19","pubTimestamp":1784546340,"startTime":"0","endTime":"0","summary":"周一,AH医药资产经历上周“黑色星期五”后率先迎来修复。港股通医药弹性十足,港股通创新药ETF华宝、港股通医疗ETF华宝大涨4.17%、3.27%。A股医药逆市活跃,药ETF华宝、医疗ETF华宝携手反弹2.5%。 港股通创新药全天强势,100%创新药研发标的——520880盘中一度上探4.63%,放量成交8.1亿元。 A股制药板块同步反弹,场内唯一跟踪制药指数的药ETF华宝低开后直线拉升翻红,盘中冲高3%,收涨2.58%走出“8天7涨”。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-07-20/doc-iniinfqe4980267.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["MEDX","159992","BK1583","520880","BK0239","LU1064131003.USD","BK1161","LU2488822045.USD","LU1969619763.USD","BK1574","IBBQ","LU1064130708.USD","09995","LU2328871848.SGD","688578","06978","688331","LU2148510915.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652251206","title":"港股通创新药突遭重挫,520880放量溢价!A股制药板块韧性凸显,场内唯一药ETF周线逆市收红","url":"https://stock-news.laohu8.com/highlight/detail?id=2652251206","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652251206?lang=zh_cn&edition=full","pubTime":"2026-07-19 20:19","pubTimestamp":1784463540,"startTime":"0","endTime":"0","summary":"7月17日,A股港股深度调整,沪指跌3%失守3800点,创指暴跌7.15%,恒指跌1.78%。普跌之际,近期显著回暖的创新药资产亦未能幸免。 港股通创新药波动剧烈,康方生物、荣昌生物等7股跌超10%,100%创新药研发标的——港股通创新药ETF华宝日内振幅达7.83%,收跌6.09%,创上市以来最大单日跌幅。不过场内持续溢价,显示买盘态度积极,或有资金逢跌介入。 A股制药板块连涨6日后突变,7股跌超10%,荣昌生物领跌15.51%,权重股科伦药业、海思科跌停。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-07-19/doc-iniikare4940014.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["06978","399300","BK1191","BK1574","IBBQ","520880","FDN","BK1161","FLHK","01477","159992","BK4550","BK4585","159982","BK4588","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652440087","title":"创新药遭“错杀”?AH十余股狂泻逾10%!港股通创新药ETF(520880)、场内唯一药ETF同创历史最大单日跌幅","url":"https://stock-news.laohu8.com/highlight/detail?id=2652440087","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652440087?lang=zh_cn&edition=full","pubTime":"2026-07-17 19:15","pubTimestamp":1784286900,"startTime":"0","endTime":"0","summary":"7月17日,A股港股深度调整,沪指跌3%失守3800点,创指暴跌7.15%,恒指跌1.78%。普跌之际,近期显著回暖的创新药资产亦未能幸免。 港股通创新药波动剧烈,康方生物、荣昌生物等7股跌超10%,100%创新药研发标的——港股通创新药ETF华宝日内振幅达7.83%,收跌6.09%,创上市以来最大单日跌幅。 本周来看,港股通创新药ETF华宝场内累跌3.79%,成交43.65亿元续创历史次高,继续放量反映热度仍高。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-07-17/doc-iniickaw4155351.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["FLHK","06978","159992","BK1161","520880","BK4550","IBBQ","BK1574","159316","BK4585","MEDX","BK4588","FDN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651491636","title":"【ETF动向】7月15日港股通创新药ETF华宝基金涨3.81%,份额减少1.1亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2651491636","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651491636?lang=zh_cn&edition=full","pubTime":"2026-07-16 06:32","pubTimestamp":1784154736,"startTime":"0","endTime":"0","summary":"证券之星消息,7月15日,港股通创新药ETF华宝基金(520880)涨3.81%,成交额11.55亿元。当日份额减少了1.1亿份,最新份额为51.98亿份,近20个交易日份额减少9.02亿份。当日资金净流入4601.24万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为24.15亿元。港股通创新药ETF华宝基金跟踪标的为恒生港股通创新药精选指数,成立(2025-06-27)以来超额回报为-4.05%,近一个月超额回报为0.45%,管理人为华宝基金公司,基金经理为丰晨成。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071600005560.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["520880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651268741","title":"创新药再度活跃!场内唯一药ETF(562050)逆市涨超1%四连升!港股通创新药ETF华宝(520880)盘中翻红!","url":"https://stock-news.laohu8.com/highlight/detail?id=2651268741","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651268741?lang=zh_cn&edition=full","pubTime":"2026-07-14 10:51","pubTimestamp":1783997460,"startTime":"0","endTime":"0","summary":" 7月14日早盘,AH创新药再度活跃,重仓A股创新药的药ETF华宝、满仓港药的港股通创新药ETF华宝双双逆市飘红。 A股制药板块震荡走高,创新药概念股科伦药业大涨超6%,百济神州、新和成涨超2%,场内唯一跟踪制药指数的药ETF华宝逆市涨超1%四连升。 值得一提的是,昨日药ETF华宝全天成交5627万元续创历史天量! 港股通创新药早盘探底回升,100%创新药研发标的——港股通创新药ETF华宝盘中翻红,振幅近3%。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/roll/2026-07-14/doc-inihtvtz7319923.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["562050","06978","BK1161","BK4588","FDN","IBBQ","159992","MEDX","520880","BK1574","BK4550","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650701130","title":"【ETF动向】7月10日港股通创新药ETF华宝基金涨3.46%,份额减少1.1亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2650701130","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650701130?lang=zh_cn&edition=full","pubTime":"2026-07-11 06:32","pubTimestamp":1783722730,"startTime":"0","endTime":"0","summary":"证券之星消息,7月10日,港股通创新药ETF华宝基金(520880)涨3.46%,成交额9.59亿元。当日份额减少了1.1亿份,最新份额为52.94亿份,近20个交易日份额减少9.24亿份。当日资金净流入2659.07万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为23.61亿元。港股通创新药ETF华宝基金跟踪标的为恒生港股通创新药精选指数,成立(2025-06-27)以来超额回报为-3.77%,近一个月超额回报为0.53%,管理人为华宝基金公司,基金经理为丰晨成。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071100004453.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["520880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650091029","title":"19亿美元!国产创新药叒爆BD大单!港股通创新药应声反弹,520880摸高2.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2650091029","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650091029?lang=zh_cn&edition=full","pubTime":"2026-07-09 10:38","pubTimestamp":1783564680,"startTime":"0","endTime":"0","summary":"创新药BD出海再添大单!中国生物制药最新公告,将旗下PDE3/4抑制剂TQC3721授予阿斯利康中国以外地区独家许可,首付款2亿美元,开发、监管及销售里程碑合计最高可达19亿美元,另享最高双位数百分比的分级特许权使用费。 二级市场火速响应,7月9日早盘,中国生物制药高开高走,一度涨超6%,所在港股通创新药板块大面积回暖,100%布局创新药研发龙头的港股通创新药ETF华宝摸高2.54%,截至发稿涨0.92%,成交超4亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-07-09/doc-inihenaz1477348.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IBBQ","520880","MEDX","159992","06978","BD","BK1574","FLHK","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1792397522230,"stockEarnings":[{"period":"1week","weight":-0.0386},{"period":"1month","weight":-0.0342},{"period":"3month","weight":-0.0208},{"period":"6month","weight":-0.2181},{"period":"1year","weight":-0.2867},{"period":"ytd","weight":-0.1506}],"compareEarnings":[{"period":"1week","weight":-0.0256},{"period":"1month","weight":-0.0451},{"period":"3month","weight":-0.0127},{"period":"6month","weight":-0.0827},{"period":"1year","weight":-0.0511},{"period":"ytd","weight":-0.0636}],"compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"港股通创新药ETF华宝(520880)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供港股通创新药ETF华宝(520880)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"港股通创新药ETF华宝,520880,港股通创新药ETF华宝股票,港股通创新药ETF华宝股票老虎,港股通创新药ETF华宝股票老虎国际,港股通创新药ETF华宝行情,港股通创新药ETF华宝股票行情,港股通创新药ETF华宝股价,港股通创新药ETF华宝股市,港股通创新药ETF华宝股票价格,港股通创新药ETF华宝股票交易,港股通创新药ETF华宝股票购买,港股通创新药ETF华宝股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"港股通创新药ETF华宝(520880)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供港股通创新药ETF华宝(520880)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}